ASTCT to Present Distinguished Honors at the 2023 Tandem Meetings
January 17, 2023 12:00 ET
|
American Society for Transplantation and Cellular Therapy
CHICAGO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- American Society for Transplantation and Cellular Therapy (ASTCT) will present top awards to leaders in the field of transplantation and cellular therapy...
Mendus AB: Mendus presenterar positiva överlevnadsdata från ADVANCE II-studien, som utvärderar DCP-001 som underhållsbehandling vid AML, på American Society of Hematology (ASH)
December 12, 2022 13:00 ET
|
Mendus AB
TISDAGEN DEN 13 DECEMBER 2022, KLOCKAN 8.00AM ET/2.00PM CET, GENOMFÖR MENDUS ETT WEBBSÄNT MÖTE, DÄR RESULTATEN SOM PRESENTERATS PÅ ASH KOMMER ATT DISKUTERAS Mendus AB (“Mendus” publ; IMMU.ST),...
Mendus AB: Mendus presents positive survival data from the ADVANCE II trial evaluating DCP-001 as a maintenance therapy in AML at the American Society of Hematology (ASH) meeting
December 12, 2022 13:00 ET
|
Mendus AB
MENDUS TO HOST A WEBCAST TO DISCUSS THE ASH DATA ON TUESDAY, DECEMBER 13, 2022 AT 8.00AM ET/2.00PM CET Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies...
UM171 cell therapy demonstrates improved outcomes compared to cord and matched unrelated donor peripheral blood transplants in real-world setting
December 12, 2022 08:25 ET
|
ExCellThera
MONTRÉAL, Dec. 12, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today findings from a safety and efficacy...
CURE Media Group announces winners of the 2022 MPN Heroes Recognition Program
December 09, 2022 11:00 ET
|
CURE Media Group
CRANBURY, N.J., Dec. 09, 2022 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to the more than one million patients,...
International Myeloma Foundation Named Winner of 2022 Amazon Web Services IMAGINE Grant for Nonprofits
December 01, 2022 08:45 ET
|
International Myeloma Foundation
STUDIO CITY, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced it has been selected as a winner of the 2022 Amazon Web Services (AWS) IMAGINE...
The Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists Will Gather for the 2023 Tandem Meetings
November 30, 2022 12:00 ET
|
American Society for Transplantation and Cellular Therapy (ASTCT)
CHICAGO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- The 2023 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® will connect the international community of hematopoietic...
ExCellThera announces completion of Phase 2 clinical trials for UM171-expanded cell therapy in high-risk blood cancers
November 15, 2022 08:32 ET
|
ExCellThera
MONTREAL, Nov. 15, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today the completion of patient enrollment in its...
ExCellThera announces 100th patient treated with UM171-expanded cell therapy
November 08, 2022 08:35 ET
|
ExCellThera
MONTREAL, Nov. 08, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today that its proprietary ECT-001 Cell Therapy...
ExCellThera announces oral presentation of new data on UM171-expanded cell therapy at the ASH Annual Meeting
November 04, 2022 09:30 ET
|
ExCellThera
MONTREAL, Nov. 04, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today that an abstract related to ExCellThera’s...